교수진
교수진
이규리
- 직위 부교수
- 학부 바이오시스템의과학부
- 연구분야 Gene Therapeutics/Vaccines, Nanomaterials for Gene Delivery, RNA-based Therapeutics, CRISPR-based Therapeutics, Cancer Immunotherapy
- 전화번호 02-3290-5649
- 연구실 하나과학관 B동 166호
- 이메일 leekyuri@korea.ac.kr
학력
2011 Ph.D, Department of Biological Sciences, KAIST, Korea
2006 B.S., College of Pharmacy, Catholic University of Daegu, Korea
2006 B.S., College of Pharmacy, Catholic University of Daegu, Korea
경력 및 수상
2020.09-2025.02 Assistant/Associate Professor, College of Pharmacy, Gyeongsang National University
2017.03.-2020.08. Research Professor, College of Pharmacy, Ewha Womans University
2016.04.-2017.02. Postdoctoral Researcher, College of Pharmacy, Ewha Womans University
2011.10.-2014.10. Postdoctoral Researcher, University of Michigan, Ann Arbor, Michigan, USA
2011.02.-2011.08. Postdoctoral Researcher, Sungkyunkwan University
더보기
2017.03.-2020.08. Research Professor, College of Pharmacy, Ewha Womans University
2016.04.-2017.02. Postdoctoral Researcher, College of Pharmacy, Ewha Womans University
2011.10.-2014.10. Postdoctoral Researcher, University of Michigan, Ann Arbor, Michigan, USA
2011.02.-2011.08. Postdoctoral Researcher, Sungkyunkwan University
연구논문
ACE mRNA (Additional Chimeric Element incorporated IVT mRNA) for Enhancing Protein Expression by Modulating Immunogenicity, Advanced Science, 2307541, 2024
Protein-RNA interaction guided chemical modification of Dicer substrate RNA nanostructures for superior in vivo gene silencing, Journal of Controlled Release, 343, 57-65, 2022
Combined hybrid structure of siRNA tailed IVT mRNA (ChriST mRNA) for enhancing DC maturation and subsequent anticancer T cell immunity”, Journal of Controlled Release, 327, 225-234, 2020
Adjuvant incorporated lipid nanoparticles for enhanced mRNA-mediated cancer immunotherapy, Biomaterials Science , 8, 1101-1105, 2020
더보기
Protein-RNA interaction guided chemical modification of Dicer substrate RNA nanostructures for superior in vivo gene silencing, Journal of Controlled Release, 343, 57-65, 2022
Combined hybrid structure of siRNA tailed IVT mRNA (ChriST mRNA) for enhancing DC maturation and subsequent anticancer T cell immunity”, Journal of Controlled Release, 327, 225-234, 2020
Adjuvant incorporated lipid nanoparticles for enhanced mRNA-mediated cancer immunotherapy, Biomaterials Science , 8, 1101-1105, 2020
